Echo Therapeutics Parts with CEO

Echo Therapeutics Announces Management Changes (via PR Newswire)

Robert Doman to Assume Role of Executive Chairman and Interim Chief Executive Officer PHILADELPHIA, Aug. 26, 2013 /PRNewswire/ — Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its non-invasive Symphony® CGM System as a needle-free,…